0000046129--12-31 2021 Q1 false 0 0 14632000 14724000 1.5 P30D 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2021-01-01 2021-03-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2020-01-01 2020-03-31 0000046129 2021-03-10 2021-03-10 0000046129 us-gaap:RetainedEarningsMember 2021-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-03-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000046129 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-03-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-03-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2021-03-31 0000046129 amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember 2021-03-31 0000046129 us-gaap:RetainedEarningsMember 2020-12-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-12-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000046129 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2020-12-31 0000046129 amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember 2020-12-31 0000046129 us-gaap:RetainedEarningsMember 2020-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-03-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000046129 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2020-03-31 0000046129 amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember 2020-03-31 0000046129 us-gaap:RetainedEarningsMember 2019-12-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000046129 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2019-12-31 0000046129 amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember 2019-12-31 0000046129 us-gaap:RestrictedStockMember 2021-03-31 0000046129 us-gaap:RestrictedStockMember 2020-12-31 0000046129 amot:VestingBasedOnPerformanceMember us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0000046129 us-gaap:RestrictedStockMember 2020-01-01 2020-03-31 0000046129 srt:EuropeMember 2021-01-01 2021-03-31 0000046129 srt:AsiaMember 2021-01-01 2021-03-31 0000046129 country:US 2021-01-01 2021-03-31 0000046129 amot:VehicleMember 2021-01-01 2021-03-31 0000046129 amot:OutsideUnitedStatesMember 2021-01-01 2021-03-31 0000046129 amot:OtherTargetMarketMember 2021-01-01 2021-03-31 0000046129 amot:MedicalMember 2021-01-01 2021-03-31 0000046129 amot:IndustrialAndElectronicsMember 2021-01-01 2021-03-31 0000046129 amot:ForeignSubsidiariesMember 2021-01-01 2021-03-31 0000046129 amot:AerospaceAndDefenseMember 2021-01-01 2021-03-31 0000046129 srt:EuropeMember 2020-01-01 2020-03-31 0000046129 srt:AsiaMember 2020-01-01 2020-03-31 0000046129 country:US 2020-01-01 2020-03-31 0000046129 amot:VehicleMember 2020-01-01 2020-03-31 0000046129 amot:OutsideUnitedStatesMember 2020-01-01 2020-03-31 0000046129 amot:OtherTargetMarketMember 2020-01-01 2020-03-31 0000046129 amot:MedicalMember 2020-01-01 2020-03-31 0000046129 amot:IndustrialAndElectronicsMember 2020-01-01 2020-03-31 0000046129 amot:ForeignSubsidiariesMember 2020-01-01 2020-03-31 0000046129 amot:AerospaceAndDefenseMember 2020-01-01 2020-03-31 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2021-01-01 2021-03-31 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0000046129 2020-01-01 2020-12-31 0000046129 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-03-31 0000046129 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-03-31 0000046129 srt:MinimumMember amot:FurnitureFixturesAndOtherMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember amot:FurnitureFixturesAndOtherMember 2021-01-01 2021-03-31 0000046129 us-gaap:MachineryAndEquipmentMember 2021-03-31 0000046129 us-gaap:LandMember 2021-03-31 0000046129 us-gaap:ConstructionInProgressMember 2021-03-31 0000046129 us-gaap:BuildingAndBuildingImprovementsMember 2021-03-31 0000046129 amot:FurnitureFixturesAndOtherMember 2021-03-31 0000046129 us-gaap:MachineryAndEquipmentMember 2020-12-31 0000046129 us-gaap:LandMember 2020-12-31 0000046129 us-gaap:ConstructionInProgressMember 2020-12-31 0000046129 us-gaap:BuildingAndBuildingImprovementsMember 2020-12-31 0000046129 amot:FurnitureFixturesAndOtherMember 2020-12-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-03-31 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-03-31 0000046129 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-03-31 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-03-31 0000046129 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-03-31 0000046129 amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember 2021-01-01 2021-03-31 0000046129 amot:AccumulatedTaxEffectOfCashFlowHedgesParentMember 2020-01-01 2020-03-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000046129 srt:ExecutiveOfficerMember 2020-01-01 2020-12-31 0000046129 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0000046129 srt:MinimumMember amot:AmendedRevolvingCreditFacilityMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember amot:AmendedRevolvingCreditFacilityMember 2021-01-01 2021-03-31 0000046129 amot:AmendedRevolvingCreditFacilityMember 2021-01-01 2021-03-31 0000046129 us-gaap:ForeignLineOfCreditMember 2021-01-01 2021-03-31 0000046129 us-gaap:ForeignLineOfCreditMember 2020-01-01 2020-03-31 0000046129 srt:ExecutiveOfficerMember 2021-03-31 0000046129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000046129 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0000046129 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0000046129 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0000046129 us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0000046129 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000046129 us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000046129 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2021-01-01 2021-03-31 0000046129 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0000046129 us-gaap:NonoperatingIncomeExpenseMember 2021-01-01 2021-03-31 0000046129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0000046129 srt:MinimumMember us-gaap:TradeNamesMember 2021-01-01 2021-03-31 0000046129 srt:MinimumMember us-gaap:CustomerListsMember 2021-01-01 2021-03-31 0000046129 srt:MinimumMember amot:DesignAndTechnologiesMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember us-gaap:TradeNamesMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember us-gaap:CustomerListsMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember amot:DesignAndTechnologiesMember 2021-01-01 2021-03-31 0000046129 us-gaap:PatentsMember 2021-01-01 2021-03-31 0000046129 us-gaap:TradeNamesMember 2021-03-31 0000046129 us-gaap:PatentsMember 2021-03-31 0000046129 us-gaap:CustomerListsMember 2021-03-31 0000046129 amot:DesignAndTechnologiesMember 2021-03-31 0000046129 us-gaap:TradeNamesMember 2020-12-31 0000046129 us-gaap:PatentsMember 2020-12-31 0000046129 us-gaap:CustomerListsMember 2020-12-31 0000046129 amot:DesignAndTechnologiesMember 2020-12-31 0000046129 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000046129 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000046129 us-gaap:ForeignExchangeContractMember 2021-03-30 0000046129 us-gaap:InterestRateSwapMember 2021-01-01 2021-03-31 0000046129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0000046129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000046129 amot:AmendedRevolvingCreditFacilityMember 2021-03-31 0000046129 us-gaap:RevolvingCreditFacilityMember 2021-03-31 0000046129 us-gaap:ForeignLineOfCreditMember 2021-03-31 0000046129 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000046129 srt:MinimumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2021-01-01 2021-03-31 0000046129 srt:MinimumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2021-01-01 2021-03-31 0000046129 srt:MaximumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-03-31 0000046129 amot:AmendedRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2021-01-01 2021-03-31 0000046129 amot:AmendedRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-03-31 0000046129 amot:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0000046129 amot:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0000046129 amot:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000046129 amot:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-03-31 0000046129 us-gaap:CommonStockMember 2021-03-31 0000046129 us-gaap:CommonStockMember 2020-12-31 0000046129 us-gaap:CommonStockMember 2020-03-31 0000046129 us-gaap:CommonStockMember 2019-12-31 0000046129 2020-03-31 0000046129 2019-12-31 0000046129 amot:OutsideUnitedStatesMember 2021-03-31 0000046129 amot:OutsideUnitedStatesMember 2020-12-31 0000046129 2021-05-05 0000046129 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000046129 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000046129 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0000046129 us-gaap:InterestRateSwapMember 2017-02-28 0000046129 srt:MinimumMember us-gaap:InterestRateSwapMember 2020-03-31 0000046129 us-gaap:InterestRateSwapMember 2020-03-31 0000046129 2021-01-01 2021-03-31 0000046129 2020-01-01 2020-03-31 0000046129 2021-03-31 0000046129 2020-12-31 iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares amot:instrument amot:derivative iso4217:CNY amot:segment

Table of Contents

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021.

OR

​

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________________to _________________________

Commission file number 0-04041

ALLIED MOTION TECHNOLOGIES INC.

(Exact name of Registrant as Specified in Its Charter)

​ | ​ | ​
Colorado |  | 84-0518115
(State or other jurisdiction of incorporation or organization) | ​ | (I.R.S. Employer Identification No.)
​ | ​ | ​
495 Commerce Drive, Amherst, New York (Address of principal executive offices) | ​ | 14228 (Zip Code)

​

(716) 242-8634

(Registrant’s Telephone Number, Including Area Code)

(Former Address, if Changed Since Last Report)

Title of each class |  | Trading Symbol |  | Name of each exchange on which registered
Common stock | ​ | AMOT | ​ | NASDAQ

​

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past ninety (90) days. Yes ⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ⌧ No ◻

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act.

​

Large accelerated filer ◻ | Accelerated filer ⌧ | Non-accelerated filer ◻ ​ | Smaller reporting company ☐ | Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ⌧

Number of Shares of the only class of Common Stock outstanding: 14,703,934 as of May 5, 2021

​

​

​

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

INDEX

​

PART I. FINANCIAL INFORMATION | Page No.
​ | ​ | ​
| Item 1. | Financial Statements |
​ | ​ | ​
| Condensed Consolidated Balance Sheets – Unaudited | 1
​ | ​ | ​
| Condensed Consolidated Statements of Income and Comprehensive Income – Unaudited | 2
​ | ​ | ​
| Condensed Consolidated Statements of Stockholders’ Equity – Unaudited | 3
​ | ​ | ​
| Condensed Consolidated Statements of Cash Flows – Unaudited | 4
​ | ​ | ​
| Notes to Condensed Consolidated Financial Statements - Unaudited | 5
​ | ​ | ​
| Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 17
​ | ​ | ​
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 22
​ | ​ | ​
| Item 4. | Controls and Procedures | 23
​ | ​
PART II. OTHER INFORMATION | 23
​ | ​ | ​
| Item 1A. | Risk Factors | 23
​ | ​ | ​ | ​
​ | Item 5. | Unregistered Sales of Equity Securities and Use of Proceeds | 24
​ | ​ | ​
| Item 6. | Other Information | 24
​ | ​ | ​
| Item 7. | Exhibits | 24

​

​

​

​

Table of Contents

​

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​ | December 31, | ​
​ |  | 2021 |  | 2020 |
Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and cash equivalents | ​ | $ | 24,725 | ​ | $ | 23,131 | ​
Trade receivables, net of provision for credit losses of $509 and $382 at March 31, 2021 and December 31, 2020, respectively | ​ | ​ | 56,252 | ​ | ​ | 47,377 | ​
Inventories | ​ |  | 61,429 | ​ |  | 62,978 | ​
Prepaid expenses and other assets | ​ |  | 7,150 | ​ |  | 8,728 | ​
Total current assets | ​ |  | 149,556 | ​ |  | 142,214 | ​
Property, plant and equipment, net | ​ |  | 54,808 | ​ |  | 55,428 | ​
Deferred income taxes | ​ |  | 7,456 | ​ |  | 330 | ​
Intangible assets, net | ​ |  | 63,856 | ​ |  | 65,859 | ​
Goodwill | ​ |  | 60,902 | ​ |  | 61,860 | ​
Right of use assets | ​ | ​ | 18,881 | ​ | ​ | 19,023 | ​
Other long-term assets | ​ |  | 4,526 | ​ |  | 4,483 | ​
Total Assets | ​ | $ | 359,985 | ​ | $ | 349,197 | ​
Liabilities and Stockholders’ Equity | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Accounts payable | ​ | $ | 32,382 | ​ | $ | 27,668 | ​
Accrued liabilities | ​ |  | 23,314 | ​ |  | 24,862 | ​
Total current liabilities | ​ |  | 55,696 | ​ |  | 52,530 | ​
Long-term debt | ​ |  | 119,882 | ​ |  | 120,079 | ​
Deferred income taxes | ​ |  | 4,658 | ​ |  | 4,659 | ​
Pension and post-retirement obligations | ​ |  | 5,045 | ​ |  | 5,340 | ​
Right of use liabilities | ​ | ​ | 14,895 | ​ | ​ | 14,975 | ​
Other long-term liabilities | ​ | ​ | 6,761 | ​ | ​ | 8,558 | ​
Total liabilities | ​ |  | 206,937 | ​ |  | 206,141 | ​
Stockholders’ Equity: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Common stock, no par value, authorized 50,000 shares; 14,724 and 14,632 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively | ​ |  | 42,936 | ​ |  | 41,278 | ​
Preferred stock, par value $1.00 per share, authorized 5,000 shares; no shares issued or outstanding | ​ |  | — | ​ |  | — | ​
Retained earnings | ​ |  | 116,698 | ​ |  | 105,065 | ​
Accumulated other comprehensive loss | ​ |  | (6,586) | ​ |  | (3,287) | ​
Total stockholders’ equity | ​ |  | 153,048 | ​ |  | 143,056 | ​
Total Liabilities and Stockholders’ Equity | ​ | $ | 359,985 | ​ | $ | 349,197 | ​

​

See accompanying notes to condensed consolidated financial statements.

​

1

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended | ​
​ | ​ | March 31, | ​
​ |  | 2021 |  | 2020 |
Revenues | ​ | $ | 101,677 | ​ | $ | 92,382 | ​
Cost of goods sold | ​ |  | 71,609 | ​ |  | 64,340 | ​
Gross profit | ​ |  | 30,068 | ​ |  | 28,042 | ​
Operating costs and expenses: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Selling | ​ |  | 4,218 | ​ |  | 4,243 | ​
General and administrative | ​ |  | 10,748 | ​ |  | 9,162 | ​
Engineering and development | ​ |  | 6,959 | ​ |  | 6,234 | ​
Business development | ​ |  | 19 | ​ |  | 247 | ​
Amortization of intangible assets | ​ |  | 1,512 | ​ |  | 1,441 | ​
Total operating costs and expenses | ​ |  | 23,456 | ​ |  | 21,327 | ​
Operating income | ​ |  | 6,612 | ​ |  | 6,715 | ​
Other expense, net: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest expense | ​ |  | 861 | ​ |  | 1,054 | ​
Other (income) expense, net | ​ |  | (119) | ​ |  | 59 | ​
Total other expense, net | ​ |  | 742 | ​ |  | 1,113 | ​
Income before income taxes | ​ |  | 5,870 | ​ |  | 5,602 | ​
Income tax benefit (provision) | ​ |  | 6,057 | ​ |  | (1,567) | ​
Net income | ​ | $ | 11,927 | ​ | $ | 4,035 | ​
Basic earnings per share: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share | ​ | $ | 0.83 | ​ | $ | 0.28 | ​
Basic weighted average common shares | ​ |  | 14,306 | ​ |  | 14,180 | ​
Diluted earnings per share: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share | ​ | $ | 0.83 | ​ | $ | 0.28 | ​
Diluted weighted average common shares | ​ |  | 14,438 | ​ |  | 14,274 | ​
Net income | ​ | $ | 11,927 | ​ | $ | 4,035 | ​
Other comprehensive income: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Foreign currency translation adjustment | ​ | ​ | (4,007) | ​ | ​ | (2,428) | ​
Gain (loss) on derivatives | ​ | ​ | 708 | ​ | ​ | (1,088) | ​
Comprehensive income | ​ | $ | 8,628 | ​ | $ | 519 | ​

​

See accompanying notes to condensed consolidated financial statements.

​

2

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except per share data)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Common Stock |  | ​ | ​ | Accumulated Other Comprehensive Income (Loss) |  | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | Unamortized | ​ | Common Stock | ​ | ​ | ​ | Currency | ​ | Accumulated | ​ | ​ | ​ | Total
​ | ​ | ​ | ​ | ​ | ​ | Cost of Equity | ​ | and Paid-in | ​ | Retained | ​ | Translation | ​ | income (loss) | ​ | Pension | ​ | Stockholders'
(In thousands except per share data) |  | Shares |  | Amount |  | Awards |  | Capital |  | Earnings |  | Adjustments |  | on derivatives |  | adjustments |  | Equity
Balances, December 31, 2020 |  | 14,632 | ​ | $ | 47,085 | ​ | $ | (5,807) | ​ | $ | 41,278 | ​ | $ | 105,065 | ​ | $ | (216) | ​ | $ | (1,438) | ​ | $ | (1,633) | ​ | $ | 143,056
Stock transactions under employee benefit stock plans |  | 32 | ​ |  | 988 | ​ | ​ | ​ | ​ | ​ | 988 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 988
Issuance of restricted stock, net of forfeitures |  | 81 | ​ |  | 3,001 | ​ |  | (2,872) | ​ | ​ | 129 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 129
Stock-based compensation expense | ​ | ​ | ​ | ​ | ​ | ​ |  | 797 | ​ | ​ | 797 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 797
Shares withheld for payment of employee payroll taxes | ​ | (21) | ​ | ​ | (256) | ​ | ​ | ​ | ​ | ​ | (256) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (256)
Comprehensive (loss) income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (4,007) | ​ | ​ | 929 | ​ | ​ | ​ | ​ | ​ | (3,078)
Tax effect of derivative transactions | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (221) | ​ | ​ | ​ | ​ | ​ | (221)
Net income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 11,927 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 11,927
Dividends to stockholders - $0.02 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (294) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (294)
Balances, March 31, 2021 |  | 14,724 | ​ | $ | 50,818 | ​ | $ | (7,882) | ​ | $ | 42,936 | ​ | $ | 116,698 | ​ | $ | (4,223) | ​ | $ | (730) | ​ | $ | (1,633) | ​ | $ | 153,048

​

​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Common Stock |  | ​ | ​ | Accumulated Other Comprehensive Income (Loss) |  | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | Unamortized | ​ | Common Stock | ​ | ​ | ​ | Currency | ​ | Accumulated | ​ | ​ | ​ | Total
​ | ​ | ​ | ​ | ​ | ​ | Cost of Equity | ​ | and Paid-in | ​ | Retained | ​ | Translation | ​ | income (loss) | ​ | Pension | ​ | Stockholders'
​ |  | Shares |  | Amount |  | Awards |  | Capital |  | Earnings |  | Adjustments |  | on derivatives |  | adjustments |  | Equity
Balances, December 31, 2019 | ​ | 14,399 | ​ | $ | 41,642 | ​ | $ | (4,506) | ​ | $ | 37,136 | ​ | $ | 92,589 | ​ | $ | (8,626) | ​ | $ | (277) | ​ | $ | (1,628) | ​ | $ | 119,194
Stock transactions under employee benefit stock plans |  | 48 | ​ |  | 1,252 | ​ | ​ | ​ | ​ | ​ | 1,252 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 1,252
Issuance of restricted stock, net of forfeitures |  | 156 | ​ |  | 3,574 | ​ |  | (3,089) | ​ | ​ | 485 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 485
Stock-based compensation expense | ​ | ​ | ​ | ​ | ​ | ​ |  | 789 | ​ | ​ | 789 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 789
Shares withheld for payment of employee payroll taxes | ​ | (36) | ​ | ​ | (256) | ​ | ​ | ​ | ​ | ​ | (256) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (256)
Comprehensive loss | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (2,428) | ​ | ​ | (1,432) | ​ | ​ | ​ | ​ | ​ | (3,860)
Tax effect | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 344 | ​ | ​ | ​ | ​ | ​ | 344
Net income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 4,035 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 4,035
Dividends to stockholders - $0.02 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (290) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (290)
Balances, March 31, 2020 |  | 14,567 | ​ | $ | 46,212 | ​ | $ | (6,806) | ​ | $ | 39,406 | ​ | $ | 96,334 | ​ | $ | (11,054) | ​ | $ | (1,365) | ​ | $ | (1,628) | ​ | $ | 121,693

​

See accompanying notes to condensed consolidated financial statements.

​

3

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended | ​
​ | ​ | March 31, | ​
​ |  | 2021 |  | 2020 |
Cash Flows From Operating Activities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 11,927 | ​ | $ | 4,035 | ​
Adjustments to reconcile net income to net cash provided by (used in) operating activities | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ |  | 4,431 | ​ |  | 3,750 | ​
Deferred income taxes | ​ |  | (7,029) | ​ |  | (488) | ​
Stock-based compensation expense | ​ | ​ | 797 | ​ | ​ | 789 | ​
Debt issue cost amortization recorded in interest expense | ​ | ​ | 35 | ​ | ​ | 38 | ​
Other | ​ |  | 890 | ​ |  | 72 | ​
Changes in operating assets and liabilities, net of acquisition: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Trade receivables | ​ |  | (9,912) | ​ |  | (7,463) | ​
Inventories | ​ |  | 56 | ​ |  | (3,978) | ​
Prepaid expenses and other assets | ​ |  | 1,862 | ​ |  | 275 | ​
Accounts payable | ​ |  | 4,994 | ​ |  | 3,043 | ​
Accrued liabilities | ​ |  | (2,484) | ​ |  | (3,039) | ​
Net cash provided by (used in) operating activities | ​ |  | 5,567 | ​ |  | (2,966) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows From Investing Activities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Purchase of property and equipment | ​ | ​ | (3,076) | ​ | ​ | (1,696) | ​
Consideration paid for acquisitions, net of cash acquired | ​ |  | — | ​ |  | (14,541) | ​
Net cash used in investing activities | ​ |  | (3,076) | ​ |  | (16,237) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows From Financing Activities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Proceeds from issuance of long-term debt | ​ |  | — | ​ |  | 26,979 | ​
Payment of debt issuance costs | ​ |  | — | ​ |  | (401) | ​
Tax withholdings related to net share settlements of restricted stock | ​ | ​ | (256) | ​ | ​ | (256) | ​
Net cash (used in) provided by financing activities | ​ |  | (256) | ​ |  | 26,322 | ​
Effect of foreign exchange rate changes on cash | ​ |  | (641) | ​ |  | (152) | ​
Net increase in cash and cash equivalents | ​ |  | 1,594 | ​ |  | 6,967 | ​
Cash and cash equivalents at beginning of period | ​ |  | 23,131 | ​ |  | 13,416 | ​
Cash and cash equivalents at end of period | ​ | $ | 24,725 | ​ | $ | 20,383 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental disclosure of cash flow information: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Property, plant and equipment purchases in accounts payable or accrued expenses | ​ | $ | 793 | ​ | $ | 540 | ​

​

See accompanying notes to condensed consolidated financial statements.

​

​

4

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

1. BASIS OF PREPARATION AND PRESENTATION

Allied Motion Technologies Inc. (“Allied Motion” or the “Company”) is engaged in the business of designing, manufacturing and selling controlled motion solutions, which include integrated system solutions as well as individual controlled motion products, to a broad spectrum of customers throughout the world. The Company’s target markets include Vehicle, Medical, Aerospace & Defense and Industrial.

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars using end of period exchange rates. Changes in reported amounts of assets and liabilities of foreign subsidiaries that occur as a result of changes in exchange rates between the foreign subsidiaries’ functional currencies and the U.S. dollar are included in foreign currency translation adjustment. Foreign currency translation adjustment is included in accumulated other comprehensive loss, a component of stockholders’ equity in the accompanying condensed consolidated statements of stockholders’ equity. Revenue and expense transactions use an average rate prevailing during the month of the related transaction. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency of each of the foreign subsidiaries are included in the results of operations as incurred.

The condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include all adjustments which are, in the opinion of management, necessary for a fair presentation. Certain information and footnote disclosures normally included in financial statements which are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures herein are adequate to make the information presented not misleading. The financial data for the interim periods may not necessarily be indicative of results to be expected for the year.

The preparation of financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.

It is suggested that the accompanying condensed consolidated financial statements be read in conjunction with the Consolidated Financial Statements and related Notes to such statements included in the Annual Report on Form 10-K for the year ended December 31, 2020 that was previously filed by the Company.

​

Stock Split

​

On March 10, 2021, the Board of Directors approved a 3-for-2 common stock split to be paid in the form of a stock dividend to holders of record on April 16, 2021. The additional shares were issued on April 30, 2021. In lieu of fractional shares, shareholders received a cash payment based on the closing share price of the common stock on the record date. All share and per share information presented in the condensed consolidated financial statements have been adjusted to reflect the stock split on a retrospective basis for all periods presented.

​

​

​

5

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

2. REVENUE RECOGNITION

Performance Obligations

Performance Obligations Satisfied at a Point in Time

The Company considers control of most products to transfer at a single point in time, generally when the products are shipped in accordance with an agreement and/or purchase order. Control is defined as the ability to direct the use of and obtain substantially all of the remaining benefits of the product.

The Company satisfies its performance obligations under a contract with a customer by transferring goods and services in exchange for monetary consideration from the customer. The Company considers the customer’s purchase order, and the Company’s corresponding sales order acknowledgment as the contract with the customer. For some customers, control, and a sale, is transferred at a point in time when the product is delivered to a customer.

Sales, value add, and other taxes we collect concurrent with revenue-producing activities are excluded from revenue.

Nature of Goods and Services

The Company sells component and integrated controlled motion solutions to end customers and original equipment manufacturers (“OEM’s”) through the Company’s own direct sales force and authorized manufacturers’ representatives and distributors. The Company’s products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products. The Company’s target markets include Vehicle, Medical, Aerospace & Defense and Industrial.

Determining the Transaction Price

The majority of the Company’s contracts have an original duration of less than one year. For these contracts, the Company applies the practical expedient and therefore does not consider the effects of the time value of money. For multiyear contracts, the Company uses judgment to determine whether there is a significant financing component. These contracts are generally those in which the customer has made an up-front payment. Contracts that management determines to include a significant financing component are discounted at the Company’s incremental borrowing rate. The Company incurs interest expense and accrues a contract liability. As the Company satisfies performance obligations and recognizes revenue from these contracts, interest expense is recognized simultaneously. Management does not have any contracts that include a significant financing component as of March 31, 2021.

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers into geographical regions and target markets. The Company determines that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. As noted below in Note 17, Segment Information, the Company’s business consists of one reportable segment. The foreign revenues by geography in the table below are revenues derived from the Company's foreign subsidiaries as detailed in Note 17.

​

6

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

A disaggregation of revenue by target market and geography is provided below (in thousands).

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended
​ | ​ | March 31,
Target Market |  | 2021 |  | 2020
Vehicle | ​ | $ | 34,451 | ​ | $ | 28,055
Industrial | ​ |  | 31,303 | ​ |  | 33,351
Medical | ​ |  | 23,289 | ​ |  | 14,551
Aerospace & Defense | ​ |  | 7,442 | ​ |  | 11,142
Other | ​ |  | 5,192 | ​ |  | 5,283
Total | ​ | $ | 101,677 | ​ | $ | 92,382

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​
​ | ​ | March 31, | ​
Geography |  | 2021 |  | 2020 | ​
United States | ​ | $ | 56,642 | ​ | $ | 56,369 | ​
Europe | ​ |  | 37,162 | ​ |  | 33,133 | ​
Asia-Pacific | ​ |  | 7,873 | ​ |  | 2,880 | ​
Total | ​ | $ | 101,677 | ​ | $ | 92,382 | ​

​

Contract Balances

When the timing of the Company’s delivery of product is different from the timing of the payments made by customers, the Company recognizes either a contract asset (performance precedes customer payment) or a contract liability (customer payment precedes performance). Typically, contracts are paid in arrears and are recognized as receivables after the Company considers whether a significant financing component exists.

The opening and closing balances of the Company’s contract liabilities are as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, |  | December 31,
​ | ​ | 2021 | ​ | 2020
Contract liabilities in accrued liabilities | ​ | $ | 801 | ​ | $ | 898
Contract liabilities in other long-term liabilities | ​ | ​ | 251 | ​ | ​ | 262
​ | ​ | $ | 1,052 | ​ | $ | 1,160

​

The difference between the opening and closing balances of the Company’s contract liabilities primarily results from the timing difference between the Company’s performance and the customer’s payment.

Significant Payment Terms

The Company’s contracts with its customers state the final terms of the sale, including the description, quantity, and price of each product or service purchased. Payments are typically due in full within 30-60 days of delivery. Since the customer agrees to a stated rate and price in the contract that do not vary over the contract, the majority of contracts do not contain variable consideration.

Returns, Refunds, and Warranties

In the normal course of business, the Company does not accept product returns unless the item is defective as manufactured. The Company establishes provisions for estimated returns and warranties. All contracts include a standard warranty clause to guarantee that the product complies with agreed specifications.

7

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

3. INVENTORIES

Inventories include costs of materials, direct labor and manufacturing overhead, and are stated at the lower of cost (first-in, first-out basis) or net realizable value, as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, |  | December 31, | ​
​ | ​ | 2021 | ​ | 2020 | ​
Parts and raw materials | ​ | $ | 44,753 | ​ | $ | 44,750 | ​
Work-in-process | ​ |  | 5,318 | ​ |  | 6,186 | ​
Finished goods | ​ |  | 11,358 | ​ |  | 12,042 | ​
​ | ​ | $ | 61,429 | ​ | $ | 62,978 | ​

​

​

4. PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment is classified as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | March 31, |  | December 31,
​ | ​ | Useful lives | ​ | 2021 | ​ | 2020
Land | ​ | ​ | ​ | $ | 987 | ​ | $ | 999
Building and improvements |  | 5 - 39 years | ​ |  | 14,086 | ​ |  | 14,169
Machinery, equipment, tools and dies |  | 3 - 15 years | ​ |  | 79,150 | ​ |  | 79,738
Construction work in progress | ​ | ​ | ​ | ​ | 6,235 | ​ | ​ | 6,821
Furniture, fixtures and other |  | 3 - 10 years | ​ |  | 18,923 | ​ |  | 16,313
​ | ​ | ​ | ​ |  | 119,381 | ​ |  | 118,040
Less accumulated depreciation | ​ | ​ | ​ |  | (64,573) | ​ |  | (62,612)
Property, plant and equipment, net | ​ | ​ | ​ | $ | 54,808 | ​ | $ | 55,428

​

Depreciation expense was approximately $2,919 and $2,309 for the three months ended March 31, 2021 and 2020, respectively.

​

5. GOODWILL

The change in the carrying amount of goodwill for the three months ended March 31, 2021 is as follows (in thousands):

​

​ | ​ | ​ | ​
​ | March 31, | ​
​ | ​ | 2021 | ​
Beginning balance | $ | 61,860 | ​
Effect of foreign currency translation |  | (958) | ​
Ending balance | $ | 60,902 | ​

​

​

6. INTANGIBLE ASSETS

Intangible assets on the Company’s condensed consolidated balance sheets consist of the following (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | March 31, 2021 | ​ | December 31, 2020
​ |  | ​ |  | Gross |  | Accumulated |  | Net Book |  | Gross |  | Accumulated |  | Net Book
​ | ​ | Life | ​ | Amount | ​ | amortization | ​ | Value | ​ | Amount | ​ | amortization | ​ | Value
Customer lists |  | 8 - 17 years | ​ | $ | 69,405 | ​ | $ | (24,520) | ​ | $ | 44,885 | ​ | $ | 69,833 | ​ | $ | (23,636) | ​ | $ | 46,197
Trade name |  | 10 - 19 years | ​ |  | 13,934 | ​ |  | (5,260) | ​ |  | 8,674 | ​ |  | 14,055 | ​ |  | (5,061) | ​ |  | 8,994
Design and technologies |  | 10 - 15 years | ​ |  | 15,232 | ​ |  | (4,946) | ​ |  | 10,286 | ​ |  | 15,531 | ​ |  | (4,874) | ​ |  | 10,657
Patents | ​ | 17 years | ​ |  | 24 | ​ |  | (13) | ​ |  | 11 | ​ |  | 24 | ​ |  | (13) | ​ |  | 11
Total | ​ | ​ | ​ | $ | 98,595 | ​ | $ | (34,739) | ​ | $ | 63,856 | ​ | $ | 99,443 | ​ | $ | (33,584) | ​ | $ | 65,859

​

Amortization expense for intangible assets was $1,512 and $1,441 for the three months ended March 31, 2021 and 2020, respectively.

8

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

Estimated future intangible asset amortization expense as of March 31, 2021 is as follows (in thousands):

​ | ​ | ​ | ​
​ | ​ | Estimated
​ |  | Amortization Expense
Remainder of 2021 | ​ | $ | 4,512
2022 | ​ |  | 6,065
2023 | ​ |  | 6,080
2024 | ​ | ​ | 5,751
2025 | ​ |  | 5,734
2026 | ​ | ​ | 5,722
Thereafter | ​ |  | 29,992
Total estimated amortization expense | ​ | $ | 63,856

​

​

​

7. STOCK-BASED COMPENSATION

Stock Incentive Plans

The Company’s Stock Incentive Plans provide for the granting of stock awards, including restricted stock, stock options and stock appreciation rights, to employees and non-employees, including directors of the Company.

Restricted Stock

For the three months ended March 31, 2021, 94,985 shares of unvested restricted stock were awarded at a weighted average market value of $31.63. Of the restricted shares granted, 62,672 shares have performance-based vesting conditions. The value of the shares is amortized to compensation expense over the related service period, which is normally three years, or over the estimated performance period. Shares of unvested restricted stock are generally forfeited if a recipient leaves the Company before the vesting date. Shares that are forfeited become available for future awards.

The following is a summary of restricted stock activity for the three-months ended March 31, 2021:

​

​ | ​ | ​
​ | ​ | Number of
​ |  | shares
Outstanding at beginning of period |  | 357,342
Awarded |  | 94,985
Vested |  | (57,855)
Forfeited |  | (9,620)
Outstanding at end of period |  | 384,852

​

Stock-based compensation expense, net of forfeitures, of $797 and $789 was recorded for the three months ended March 31, 2021 and 2020, respectively.

​

9

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

8. ACCRUED LIABILITIES

Accrued liabilities consist of the following (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​ | December 31,
​ |  | 2021 |  | 2020
Compensation and fringe benefits | ​ | $ | 9,408 | ​ | $ | 11,184
Warranty reserve | ​ |  | 2,119 | ​ |  | 1,571
Income taxes payable | ​ | ​ | 1,753 | ​ | ​ | 1,459
Right of use liabilities | ​ | ​ | 4,543 | ​ | ​ | 4,666
Other accrued expenses | ​ |  | 5,491 | ​ |  | 5,982
​ | ​ | $ | 23,314 | ​ | $ | 24,862

​

Changes in the Company’s reserve for product warranty claims during 2021 were as follows (in thousands):

​

​ | ​ | ​ | ​
​ | March 31, | ​
​ | 2021 |
Warranty reserve at beginning of the year | $ | 1,571 | ​
Provision |  | 608 | ​
Warranty expenditures |  | (35) | ​
Effect of foreign currency translation |  | (25) | ​
Warranty reserve at end of year | $ | 2,119 | ​

​

​

9. DEBT OBLIGATIONS

Debt obligations consisted of the following (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​ | December 31,
​ |  | 2021 |  | 2020
Long-term Debt | ​ | ​ | ​ | ​ | ​ | ​
Revolving Credit Facility, long-term (1) | ​ | $ | 120,424 | ​ | $ | 120,656
Unamortized debt issuance costs | ​ | ​ | (542) | ​ | ​ | (577)
Long-term debt | ​ | $ | 119,882 | ​ | $ | 120,079

| (1) | The effective rate of the Amended Revolving Facility is 2.49% at March 31, 2021.

Amended Revolving Credit Facility

The First Amended and Restated Credit Agreement (the “Amended Credit Agreement”) includes a $225 million revolving credit facility (the “Amended Revolving Facility”). The Amended Credit Agreement includes (i) a maximum principal amount of $225 million, (ii) a $75 million accordion amount, and (iii) a maturity date of February 2025.

Borrowings under the Amended Revolving Facility bear interest at the LIBOR Rate (as defined in the Amended Credit Agreement) plus a margin of 1.00% to 1.75% or the Prime Rate (as defined in the Amended Credit Agreement) plus a margin of 0% to 0.75%, in each case depending on the Company’s ratio of total funded indebtedness (as defined in the Amended Credit Agreement) to Consolidated trailing twelve-month EBITDA (the “Total Leverage Ratio”). At March 31, 2021, the applicable margin for LIBOR Rate borrowings was 1.625% and the applicable margin for Prime Rate borrowings was 0.625%. In addition, the Company is required to pay a commitment fee of between 0.10% and 0.225% quarterly (0.20% at March 31, 2021) on the unused portion of the Amended Revolving Facility, also based on the Company’s Total Leverage Ratio. The Amended Revolving Facility is secured by substantially all of the Company’s non-realty assets and is fully and unconditionally guaranteed by certain of the Company’s subsidiaries.

The Amended Credit Agreement contains certain financial covenants related to minimum interest coverage and total leverage ratio at the end of each quarter. The Amended Credit Agreement also includes other covenants and restrictions, including limits on the amount

10

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

of additional indebtedness, and restrictions on the Company’s ability to merge or sell all, or substantially all, of its assets. The Company was in compliance with all covenants at March 31, 2021.

As of March 31, 2021, the unused Amended Revolving Facility was $104,576. The amount available to borrow may be reduced based upon the Company’s debt and EBITDA levels, which impacts its covenant calculations.

Other

The China Credit Facility provides credit of $1,526 (Chinese Renminbi 10,000) (“the China Facility”). The China Facility is a demand revolving facility used for working capital and capital equipment needs at the Company’s China operations. The term is annual and may be cancelled at the bank’s discretion. The interest rate shall be agreed upon by the Lender and the Borrower before the Utilization Date (as defined in the China Facility) and shall be specified in the Utilization Request (as defined in the China Facility). Collateral for the facility is a guarantee issued by the Company. There have been no borrowings during the three months ended March 31, 2021 or 2020, respectively, and there is no balance in the China Facility at March 31, 2021 and December 31, 2020.

​

​

10. DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, and foreign exchange risk primarily through the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash payments principally related to the Company’s borrowings.

Beginning in the first quarter of 2021, the Company began entering into contracts with 30-day maturities to hedge its short-term balance sheet exposure, primarily intercompany, that are denominated in currencies (Euro, Mexican Peso, New Zealand Dollar, Chinese Renminbi) other than the subsidiary’s functional currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in other (income) expense, net in the condensed consolidated statements of income and comprehensive income. To minimize foreign currency exposure, the Company had foreign currency contracts with notional amounts of $8,000 at March 30, 2021. The foreign currency contracts are recorded in the condensed consolidated balance sheets at fair value and resulting gains or losses are recorded in other (income) expense, net in the condensed consolidated statements of income and comprehensive income. During the first quarter of 2021, we recorded a $140 loss on foreign currency contracts which is included in other (income) expense, net and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other (income) expense, net.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In February 2017, the Company entered into three interest rate swaps with a combined notional amount of $40,000 that mature in February 2022. In March 2020, the Company entered into two additional interest rate swaps with a combined notional amount of $20,000 that increases to $60,000 in March 2022 and matures in December 2024.

The changes in the fair value of interest rate derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive loss and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During 2021 and 2020, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.

The Company estimates that an additional $860 will be reclassified as an increase to interest expense over the next twelve months. Additionally, the Company does not use derivatives for trading or speculative purposes.

11

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020 (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Liability Derivatives | ​
​ | ​ | ​ | ​ | Fair value as of: | ​
Derivatives designated as | ​ | Balance Sheet | ​ | March 31, | ​ | December 31, | ​
hedging instruments |  | Location |  | 2021 |  | 2020 |
Interest rate products | ​ | Accrued liabilities | ​ | $ | 677 | ​ | $ | — | ​
Interest rate products | ​ | Other long-term liabilities | ​ | ​ | 284 | ​ | ​ | 1,889 | ​
Foreign currency contracts | ​ | Accrued liabilities | ​ | ​ | 14 | ​ | ​ | — | ​
​ | ​ | ​ | ​ | $ | 975 | ​ | $ | 1,889 | ​

​

The tables below present the effect of cash flow hedge accounting on other comprehensive income (loss) (“OCI”) for the three months ended March 31, 2021 and 2020 (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of pre-tax gain (loss) recognized | ​
​ | ​ | in OCI on derivatives | ​
Derivatives in cash flow hedging relationships | ​ | Three months ended March 31, | ​
​ |  | 2021 |  | 2020 |
Interest rate products | ​ | $ | 704 | ​ | $ | (1,463) | ​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of pre-tax (loss) gain reclassified | ​
​ | ​ | from accumulated OCI into income | ​
Location of (loss) gain reclassified | ​ | Three months ended March 31, | ​
from accumulated OCI into income |  | 2021 |  | 2020 | ​
​ |  | ​ | ​ |  | ​ | ​ |
Interest expense | ​ | $ | (225) | ​ | $ | (31) | ​

​

The table below presents the effect of the Company’s derivative financial instruments on the condensed consolidated statements of income and comprehensive income for the three months ended March 31, 2021 and 2020 (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Total amounts of income and expense | ​
​ | ​ | ​ | ​ | line items presented that reflect the | ​
​ | ​ | ​ | ​ | effects of cash flow hedges recorded | ​
​ | ​ | ​ | ​ | Three months ended March 31, | ​
Derivatives designated as hedging instruments |  | Income Statement Location |  | 2021 |  | 2020 |
Interest rate products |  | Interest Expense | ​ | $ | 861 | ​ | $ | 1,054 | ​

​

​

12

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of March 31, 2021 and December 31, 2020. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented in the condensed consolidated balance sheets (in thousands).

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Gross amounts | ​ | Net amounts of liabilities | ​ | Gross amounts not offset in the consolidated
As of | ​ | Gross amounts | ​ | offset in the | ​ | presented in the | ​ | balance sheets
March 31, | ​ | of recognized | ​ | consolidated | ​ | consolidated | ​ | Financial | ​ | Cash collateral | ​ | ​ | ​
2021 |  | liabilities |  | balance sheets |  | balance sheets |  | instruments |  | received |  | Net amount
Derivatives | ​ | $ | 983 | ​ | $ | 8 | ​ | $ | 975 | ​ | $ | — | ​ | $ | — | ​ | $ | 975

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Gross amounts | ​ | Net amounts of liabilities | ​ | Gross amounts not offset in the consolidated
As of | ​ | Gross amounts | ​ | offset in the | ​ | presented in the | ​ | balance sheets
December 31, | ​ | of recognized | ​ | consolidated | ​ | consolidated | ​ | Financial | ​ | Cash collateral | ​ | ​ | ​
2020 |  | liabilities |  | balance sheets |  | balance sheets |  | instruments |  | received |  | Net amount
Derivatives | ​ | $ | 1,889 | ​ | $ | — | ​ | $ | 1,889 | ​ | $ | — | ​ | $ | — | ​ | $ | 1,889

​

The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations.

​

11. FAIR VALUE

Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.

The guidance establishes a framework for measuring fair value which utilizes observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. Preference is given to observable inputs.

These two types of inputs create the following three - level fair value hierarchy:

Level 1: | Quoted prices for identical assets or liabilities in active markets.
Level 2: | Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model - derived valuations whose inputs or significant value drivers are observable.
Level 3: | Significant inputs to the valuation model that are unobservable. ​

The Company’s financial assets and liabilities include cash and cash equivalents, accounts receivable, debt obligations, accounts payable, and accrued liabilities. The carrying amounts reported in the condensed consolidated balance sheets for these assets and liabilities approximate their fair value because of the immediate or short-term maturities of these financial instruments.

The following tables presents the Company’s financial assets that are accounted for at fair value on a recurring basis as of March 31, 2021 and December 31, 2020, respectively, by level within the fair value hierarchy (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, 2021
​ |  | Level 1 |  | Level 2 |  | Level 3
Assets (liabilities) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pension plan assets | ​ | $ | 6,685 | ​ | $ | — | ​ | $ | —
Deferred compensation plan assets | ​ |  | 4,365 | ​ |  | — | ​ |  | —
Interest rate swaps | ​ |  | — | ​ |  | (961) | ​ |  | —
Foreign currency hedge contracts | ​ |  | — | ​ |  | (14) | ​ |  | —

​

13

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2020
​ |  | Level 1 |  | Level 2 |  | Level 3
Assets (liabilities) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pension plan assets | ​ | $ | 6,347 | ​ | $ | — | ​ | $ | —
Deferred compensation plan assets | ​ |  | 5,386 | ​ |  | — | ​ |  | —
Interest rate swaps | ​ |  | — | ​ |  | (1,889) | ​ |  | —

​

​

12. INCOME TAXES

The income tax provision for interim periods is determined using an estimate of the annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the estimate of the annual effective tax rate is updated, and if the estimated effective tax rate changes, a cumulative adjustment is made. There is a potential for volatility of the effective tax rate due to several factors, including changes in the mix of the pre-tax income and the jurisdictions to which it relates, changes in tax laws, settlements with taxing authorities and foreign currency fluctuations.

​

The effective income tax rate as a percentage of income before income taxes was (103.2)% and 28.0% for the three months ended March 31, 2021 and 2020, respectively. The effective tax rate is net of a discrete tax benefit of (130.5)% and a discrete tax expense of 0.3%, for the three months ended March 31, 2021 and 2020, respectively. The discrete benefit in the three months ended March 31, 2021 is related primarily to the recognition of net operating loss carryforwards resulting from tax legislation enacted in New Zealand during the period which changes our ability to use the carryforwards in future periods. The discrete tax expense for the three months ended March 31, 2020 related primarily to share-based payments.

13. LEASES

The Company has operating leases for office space, manufacturing equipment, computer equipment and automobiles. Many leases include one or more options to renew, some of which include options to extend the leases for a long-term period, and some leases include options to terminate the leases within 30 days. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for capital area maintenance, utilities, inflation and/or changes in other indexes.

Short term and variable lease expense were not material in any of the periods presented.

​

Supplemental cash flow information related to the Company’s operating leases for the three months ended March 31, 2021 and 2020 was as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​
​ | ​ | 2021 | ​ | 2020 | ​
Cash paid for amounts included in the measurement of operating leases |  | $ | 1,339 |  | $ | 1,001 |
ROU assets obtained in exchange for operating lease obligations | ​ | $ | 1,553 | ​ | $ | 2,710 | ​

​

​

The following table presents the maturity of the Company’s operating lease liabilities as of March 31, 2021 (in thousands):

​

​ | ​ | ​ | ​
Remainder of 2021 |  | $ | 3,773
2022 |  | ​ | 4,094
2023 | ​ |  | 3,045
2024 | ​ |  | 2,368
2025 | ​ | ​ | 2,183
2026 | ​ | ​ | 1,146
Thereafter | ​ |  | 4,327
Total undiscounted cash flows | ​ | $ | 20,936
Less: present value discount | ​ | ​ | (1,498)
Total lease liabilities | ​ | $ | 19,438

​

14

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

As of March 31, 2021, the Company had no additional significant operating or finance leases that had not yet commenced.

The Company leases certain facilities from a company for which one of our executive officers is a part owner. In connection with such leases, the Company made payments to the lessor of $0.5 million during the year ended December 31, 2020 and is obligated to make payments of $0.7 million during the year ending December 31, 2021. Future minimum lease payments under the leases as of March 31, 2021 are $8.4 million.

14. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Accumulated Other Comprehensive Income (Loss) (“AOCI”) for the three months ended March 31, 2021 and 2020 is comprised of the following (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign Currency | ​ | ​ | ​
​ | ​ | Defined Benefit | ​ | ​ | ​ | Tax effect of | ​ | Translation | ​ | ​ | ​
​ |  | Plan Liability |  | Cash Flow Hedges |  | Cash Flow Hedges |  | Adjustment |  | Total
At December 31, 2020 | ​ | $ | (1,633) | ​ | $ | (1,889) | ​ | $ | 451 | ​ | $ | (216) | ​ | $ | (3,287)
Unrealized gain on cash flow hedges | ​ | ​ | — | ​ | ​ | 704 | ​ | ​ | (167) | ​ | ​ | — | ​ | ​ | 537
Amounts reclassified from AOCI | ​ | ​ | — | ​ | ​ | 225 | ​ | ​ | (54) | ​ | ​ | — | ​ | ​ | 171
Foreign currency translation loss | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (4,007) | ​ | ​ | (4,007)
At March 31, 2021 | ​ | $ | (1,633) | ​ | $ | (960) | ​ | $ | 230 | ​ | $ | (4,223) | ​ | $ | (6,586)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign Currency | ​ | ​ | ​
​ | ​ | Defined Benefit | ​ | ​ | ​ | Tax effect of | ​ | Translation | ​ | ​ | ​
​ |  | Plan Liability |  | Cash Flow Hedges |  | Cash Flow Hedges |  | Adjustment |  | Total
At December 31, 2019 | ​ | $ | (1,628) | ​ | $ | (363) | ​ | $ | 86 | ​ | $ | (8,626) | ​ | $ | (10,531)
Unrealized loss on cash flow hedges | ​ | ​ | — | ​ | ​ | (1,463) | ​ | ​ | 351 | ​ | ​ | — | ​ | ​ | (1,112)
Amounts reclassified from AOCI | ​ | ​ | — | ​ | ​ | 31 | ​ | ​ | (7) | ​ | ​ | — | ​ | ​ | 24
Foreign currency translation loss | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (2,428) | ​ | ​ | (2,428)
At March 31, 2020 | ​ | $ | (1,628) | ​ | $ | (1,795) | ​ | $ | 430 | ​ | $ | (11,054) | ​ | $ | (14,047)

​

The realized losses relating to the Company’s interest rate swap hedges were reclassified from accumulated other comprehensive income (loss) and included in interest expense in the condensed consolidated statements of income and comprehensive income.

15. DIVIDENDS PER SHARE

The Company declared a quarterly dividend of $0.02 per share in the three months ended March 31, 2021 and 2020, respectively. Total dividends declared were $294 and $290 in the three months ended March 31, 2021 and 2020, respectively. The declared dividends were paid in April 2021 and 2020, respectively.

16. EARNINGS PER SHARE

Basic and diluted weighted-average shares outstanding are as follows (in thousands):

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​
​ | ​ | March 31, | ​
​ |  | 2021 |  | 2020 |
Basic weighted average shares outstanding |  | 14,306 |  | 14,180 |
Dilutive effect of equity awards |  | 132 |  | 94 |
Diluted weighted average shares outstanding |  | 14,438 |  | 14,274 |

​

For the three months ended March 31, 2021 and 2020, the anti-dilutive common shares excluded from the calculation of diluted earnings per share were immaterial.

15

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

17. SEGMENT INFORMATION

The Company operates in one segment for the manufacture and marketing of controlled motion products for end user and OEM applications. The Company’s chief operating decision maker is the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services in which the entity holds material assets and reports revenue.

Financial information related to the foreign subsidiaries is summarized below (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​
​ | ​ | March 31, | ​
​ |  | 2021 |  | 2020 |
Revenues derived from foreign subsidiaries | ​ | $ | 45,035 | ​ | $ | 36,013 | ​

​

Revenues derived from foreign subsidiaries and identifiable assets outside of the United States are attributable to Europe and Asia-Pacific.

Identifiable foreign assets were $133,775 and $133,466 as of March 31, 2021 and December 31, 2020, respectively.

Sales to customers outside of the United States by all subsidiaries were $49,655 and $43,389 during the three months ended March 31, 2021 and 2020, respectively.

For the three months ended March 31, 2021 and 2020, one customer accounted for 16% and 13% of revenues, respectively. As of March 31, 2021 and December 31, 2020 this customer represented 19% and 22% of trade receivables, respectively.

18. RECENT ACCOUNTING PRONOUNCEMENTS

Recently adopted accounting pronouncements

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). The standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, and clarifies existing guidance to improve consistent application. This guidance is effective for fiscal years beginning after December 15, 2020. The Company adopted this ASU on January 1, 2021 on a prospective basis, as there were no relevant matters impacting the Company for which retrospective application was required, and the adoption did not have a material impact on its condensed consolidated financial statements.

​

16

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

All statements contained herein that are not statements of historical fact constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and may contain the word “believe,” “anticipate,” “expect,” “project,” “intend,” “will continue,” “will likely result,” “should” or words or phrases of similar meaning. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from the expected results described in the forward-looking statements. The risks and uncertainties include those associated with: the domestic and foreign general business and economic conditions in the markets we serve, including political and currency risks and adverse changes in local legal and regulatory environments; the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses’ and governments’ responses to the pandemic on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains; our inability to predict the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives; the introduction of new technologies and the impact of competitive products; the ability to protect the Company’s intellectual property; our ability to sustain, manage or forecast its growth and product acceptance to accurately align capacity with demand; the continued success of our customers and the ability to realize the full amounts reflected in our order backlog as revenue; the loss of significant customers or the enforceability of the Company’s contracts in connection with a merger, acquisition, disposition, bankruptcy, or otherwise; our ability to meet the technical specifications of our customers; the performance of subcontractors or suppliers and the continued availability of parts and components; changes in government regulations; the availability of financing and our access to capital markets, borrowings, or financial transactions to hedge certain risks; the ability to attract and retain qualified personnel who can design new applications and products for the motion industry; the ability to implement our corporate strategies designed for growth and improvement in profits including to identify and consummate favorable acquisitions to support external growth and the development of new technologies; the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems; our ability to control costs, including the establishment and operation of low cost region manufacturing and component sourcing capabilities; and the additional risk factors discussed under “Item 1A. Risk Factors” in Part II of this report and in the Company’s Annual Report in Form 10-K. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on these forward- looking statements as a prediction of actual results. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward-looking statements, whether as a result of new information, future events, or otherwise.

New risk factors emerge from time to time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company’s expectations, beliefs and projections are believed to have a reasonable basis; however, the Company makes no assurance that expectations, beliefs or projections will be achieved.

Overview

We are a global company that designs, manufactures and sells precision and specialty controlled motion components and systems used in a broad range of industries. Our target markets include Vehicle, Medical, Aerospace & Defense, and Industrial. We are headquartered in Amherst, NY, and have operations in the North America, Europe and Asia-Pacific. We are known worldwide for our expertise in electro-magnetic, mechanical and electronic motion technology. We sell component and integrated controlled motion solutions to end customers and OEMs through our own direct sales force and authorized manufacturers’ representatives and distributors. Our products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products.

Business Environment

The ongoing outbreak of the novel strain of Coronavirus (“COVID-19”) will continue to create significant disruptions to the U.S. and global economies and will continue to adversely affect portions of our business, including our supply chain and operations. We have experienced reductions in customer demand in several of our served markets during periods of 2020 and 2021 due to the impact of COVID-19, however we have experienced rebounds in several other served markets, including a record level of total bookings in the

17

Table of Contents

first quarter of 2021. We have been impacted by reduced operational status of our suppliers which has impacted the predictability of our supply chain. During 2021, we expect the impact of COVID-19 on our operations will continue to challenge many aspects of our business, particularly our supply chain, while providing opportunities in certain markets.

In response to the worldwide outbreak, we have taken and will continue to take proactive, aggressive action to protect the health and safety of our employees, customers, partners, suppliers and communities. We enacted rigorous safety measures in all of our sites, including implementing social distancing protocols, incorporating a work from home environment at certain times for those employees that do not need to be physically present on the manufacturing floor or in a lab to perform their work, suspending travel, implementing temperature checks at the entrances to our facilities, extensively and frequently disinfecting our workspaces and providing masks and other protective equipment to those employees who must be physically present. These measures have been implemented on a worldwide basis and we are continuing to monitor and act in accordance with government authorities requirements or recommendations and evolving best practices.

Our Company provides essential and important products, including those that our customers rely on to address COVID-19. We manufacture and deliver critical motion control components, including electronic drives, motors and control assemblies to manufacturers of medical equipment including respirators, ventilators, infusion pumps, medical fluid pumps and other breathing assist equipment required to care for patients with respiratory issues including COVID-19. We are also a long-term, qualified supplier to leading medical device manufacturers of ventilators and respirators around the world.

Global demand and capacity to produce ventilators increased significantly during portions of 2020, and we are a reliable supplier of the critical motion control components it requires. The Company rapidly deployed resources to increase production capacity to meet the surge in demand that has been experienced for certain types of medical products related to combatting the COVID-19 virus. While the demand for certain items, such as ventilators, is returning to normalized levels, we also continue to provide solutions to suppliers of other types of medical equipment, including surgical tools and equipment, surgical robots, diagnostic equipment, test equipment, patient mobility and rehabilitation equipment, hospital beds and mobile equipment carts.

Our worldwide locations are considered to be essential suppliers to our customers and therefore most of our locations have remained substantially operational during the outbreak while implementing the enhanced safety procedures.

We have taken actions since the beginning of the pandemic to strengthen our liquidity and financial condition. We renewed and increased our revolving credit facility (“Amended Revolving Facility”) to $225 million through February 2025 (refer to Note 9, Debt Obligations from our condensed consolidated financial statements). Through this amendment we lowered our cost of debt, and secured more favorable covenants. This liquidity preserves our financial flexibility during the pandemic and subsequent to it. We believe that our cash flows from operations and borrowing capacity are sufficient to support our short and long-term liquidity needs.

To conserve cash and maximize operational efficiency while supporting growth plans, we are continuing to align variable costs with demand, maintaining key engineering capabilities, and controlling discretionary spending. The Company continues to closely monitor events and conditions resulting from COVID-19 and the resulting impact on all forms of incentive compensation.

The extent of the impact of the COVID-19 outbreak on our operational and financial performance will continue to depend on future developments, including the duration and spread of the virus, the potential for additional waves, its impact on our customers and the range of governmental reactions to the pandemic, which cannot be predicted at this time. We will continue to proactively respond to the situation and will take further actions as warranted to alter our business operations as necessary.

Stock Split

On April 30, 2021, we effected a 3-for-2 stock split. References to numbers of shares of common stock and per share data have been adjusted to reflect the stock split on a retrospective basis. Refer to Note 1, Basis of Preparation and Presentation in the notes to condensed consolidated financial statements of Part I, Item 1 of this Form 10-Q for further information.

Recent Accounting Pronouncements

Refer to Note 18, Recent Accounting Pronouncements in the notes to condensed consolidated financial statements of Part 1, Item 1 of this Form 10-Q for information regarding recently adopted accounting standards and their potential impact on our financial condition or results of operations.

18

Table of Contents

Operating Results

Quarter ended March 31, 2021 compared to quarter ended March 31, 2020

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended |  | 2021 vs. 2020 | ​
​ | ​ | March 31, | ​ | Variance |
(Dollars in thousands, except per share data) |  | 2021 |  | 2020 | ​ | $ |  | % | ​
Revenues | ​ | $ | 101,677 | ​ | $ | 92,382 | ​ | $ | 9,295 | ​ | 10 | %
Cost of goods sold | ​ |  | 71,609 | ​ |  | 64,340 | ​ |  | 7,269 | ​ | 11 | %
Gross profit | ​ |  | 30,068 | ​ |  | 28,042 | ​ |  | 2,026 | ​ | 7 | %
Gross margin percentage | ​ |  | 29.6 | % |  | 30.4 | % |  |  | ​ |  | ​
Operating costs and expenses: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  | ​
Selling | ​ |  | 4,218 | ​ |  | 4,243 | ​ |  | (25) | ​ | (1) | %
General and administrative | ​ |  | 10,748 | ​ |  | 9,162 | ​ |  | 1,586 | ​ | 17 | %
Engineering and development | ​ |  | 6,959 | ​ |  | 6,234 | ​ |  | 725 | ​ | 12 | %
Business development | ​ |  | 19 | ​ |  | 247 | ​ |  | (228) | ​ | (92) | %
Amortization of intangible assets | ​ |  | 1,512 | ​ |  | 1,441 | ​ |  | 71 | ​ | 5 | %
Total operating costs and expenses | ​ |  | 23,456 | ​ |  | 21,327 | ​ |  | 2,129 | ​ | 10 | %
Operating income | ​ |  | 6,612 | ​ |  | 6,715 | ​ |  | (103) | ​ | (2) | %
Interest expense | ​ |  | 861 | ​ |  | 1,054 | ​ |  | (193) | ​ | (18) | %
Other (income) expense, net | ​ |  | (119) | ​ |  | 59 | ​ |  | (178) | ​ | (302) | %
Total other expense | ​ |  | 742 | ​ |  | 1,113 | ​ |  | (371) | ​ | (33) | %
Income before income taxes | ​ |  | 5,870 | ​ |  | 5,602 | ​ |  | 268 | ​ | 5 | %
Income tax benefit (provision) | ​ |  | 6,057 | ​ |  | (1,567) | ​ |  | 7,624 | ​ | (487) | %
Net income | ​ | $ | 11,927 | ​ | $ | 4,035 | ​ | $ | 7,892 | ​ | 196 | %
​ | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  | ​
Effective tax rate | ​ |  | (103.2) | % |  | 28.0 | % |  | (131.2) | ​ | (469) | %
Diluted earnings per share | ​ | $ | 0.83 | ​ | $ | 0.28 | ​ | $ | 0.55 | ​ | 196 | %
Bookings | ​ | $ | 114,644 | ​ | $ | 92,923 | ​ | $ | 21,721 | ​ | 23 | %
Backlog | ​ | $ | 152,262 | ​ | $ | 133,187 | ​ | $ | 19,075 | ​ | 14 | %

​

REVENUES: For the quarter, the increase in revenues reflects improved sales in certain markets we serve, specifically Medical and Vehicle. The addition of Dynamic Controls for a full quarter and the strong demand for medical equipment contributed to the strong Medical market revenues during the quarter. These increases were partially offset by declines primarily in our Industrial and Aerospace & Defense markets.

​

Sales to U.S. customers were 51% of total sales for the first quarter 2021 compared with 53% for the same period last year, with the balance of sales to customers primarily in Europe, Canada and Asia-Pacific. The overall increase in revenue was due to a 5.4% volume increase in addition to a 4.6% favorable currency impact. See information included in “Non – GAAP Measures” below for a discussion of the non-GAAP measure and a reconciliation of revenue to revenue excluding foreign currency impacts.

​

ORDER BOOKINGS AND BACKLOG: We experienced a record level of bookings during the first quarter of 2021. The increase in bookings in the first quarter of 2021 compared to the first quarter of 2020 is largely due to increases in our Medical and Vehicle markets, including a full quarter of bookings from Dynamic Controls. The increase in backlog as of March 31, 2021, compared to at March 31, 2020 was also related to these factors.

​

GROSS PROFIT AND GROSS MARGIN: Gross margin decreased to 29.6% for the first quarter of 2021, compared to 30.4% for the first quarter of 2020. The decrease in gross margin percentage was largely driven by increased costs resulting from the tight supply chain and the decision to incur incremental costs to ensure on time deliveries to customers. Additionally, we incurred higher than normal warranty costs during the first quarter of 2021 due to a warranty claim during the period.

​

SELLING EXPENSES: Selling expenses decreased 1% in the first quarter of 2021 compared to the same period of 2020. The addition of Dynamic Controls for a full quarter was offset by cost control efforts related to the COVID-19 pandemic, specifically travel restrictions. Selling expenses as a percentage of revenues were 4.1% in the first quarter of 2021 compared to 4.6% for the same period last year.

​

19

Table of Contents

GENERAL AND ADMINISTRATIVE EXPENSES: General and administrative expenses increased by 17% in the first quarter 2021 from the first quarter 2020 due to the incremental expenses from Dynamic Controls for a full quarter and costs associated with incentive compensation. As a percentage of revenues, general and administrative expenses were 10.6% for the quarter ended March 31, 2021 compared to 9.9% for the same period in 2020.

​

ENGINEERING AND DEVELOPMENT EXPENSES: Engineering and development expenses increased by 12% in the first quarter of 2021 compared to the same quarter last year. Part of the increase relates to the addition of Dynamic Controls for a full quarter, whose focus is electronics and software engineering. The increase is also due to the continued ramp up of development projects to meet the future needs of target markets, as well as supporting growing customer application development needs. As a percentage of revenues, engineering and development expenses were 6.8% for the quarter ended March 31, 2021 compared to 6.7% for the same period in 2020.

​

AMORTIZATION OF INTANGIBLE ASSETS: Amortization expense increased 5% in the first quarter of 2021 compared to the first quarter of 2020 due to the 2021 interim period including a full quarter of amortization of the intangible assets acquired in the acquisition of Dynamic Controls.

​

INTEREST EXPENSE: Interest expense decreased by $193 in the first quarter 2021 due to lower interest rates compared to the same period in 2020.

​

INCOME TAXES: The effective income tax rate as a percentage of income before income taxes was (103.2)% and 28.0% in the first quarter 2021 and 2020, respectively. The effective tax rate is net of a discrete tax benefit of (130.5)% and a discrete tax expense of 0.3%, for the first quarters of 2021 and 2020, respectively. The discrete benefit in the first quarter of 2021 is primarily related to the recognition of net operating loss carryforwards resulting from tax legislation enacted in New Zealand during the period.

​

NET INCOME: Net income increased during the first quarter 2021 compared to the first quarter 2020 reflecting the results of increased revenue, as well as the effect of a $7.4 million discrete tax benefit in the current period, partially offset to some extent by increased operating expenses as a result of the inclusion of Dynamic Controls for a full quarter.

​

EBITDA AND ADJUSTED EBITDA: EBITDA was $11,162 for the first quarter of 2021 compared to $10,406 for the same quarter last year. The increase in the first quarter of 2021 compared to the first quarter of 2020 is primarily due to higher gross profit driven by sales growth, partially offset by lower gross margins and increased operating expenses. Adjusted EBITDA was $11,966 and $11,534 for the first quarters of 2021 and 2020, respectively. EBITDA and Adjusted EBITDA are non-GAAP measurements. EBITDA consists of income before interest expense, benefit (provision) for income taxes, and depreciation and amortization. Adjusted EBITDA also excludes stock-based compensation expense, foreign currency gain/loss, and certain other items. Refer to information included in “Non-GAAP Measures” below for a reconciliation of net income to EBITDA and Adjusted EBITDA.

Non-GAAP Measures

Revenue excluding foreign currency exchange impacts, EBITDA and Adjusted EBITDA are provided for information purposes only and are not measures of financial performance under GAAP.

Management believes the presentation of these financial measures reflecting non-GAAP adjustments provides important supplemental information to investors and other users of our financial statements in evaluating the operating results of the Company as distinct from results that include items that are not indicative of ongoing operating results. In particular, those charges and credits that are not directly related to operating unit performance, and that are not a helpful measure of the performance of our underlying business particularly in light of their unpredictable nature. These non-GAAP disclosures have limitations as analytical tools, should not be viewed as a substitute for revenue and net income determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP, nor is it necessarily comparable to non-GAAP performance measures that may be presented by other companies. In addition, supplemental presentation should not be construed as an inference that the Company’s future results will be unaffected by similar adjustments to net income determined in accordance with GAAP.

The Company believes that revenue excluding foreign currency exchange impacts is a useful measure in analyzing sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to

20

Table of Contents

currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period.

The Company believes EBITDA is often a useful measure of a Company’s operating performance and is a significant basis used by the Company’s management to measure the operating performance of the Company’s business because EBITDA excludes charges for depreciation, amortization and interest expense that have resulted from our debt financings, acquisitions, as well as our provision for income tax expense. EBITDA is frequently used as one of the bases for comparing businesses in the Company’s industry.

The Company also believes that Adjusted EBITDA provides helpful information about the operating performance of its business. Adjusted EBITDA excludes stock-based compensation expense, as well as certain income or expenses which are not indicative of the ongoing performance of the Company. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.

The Company’s calculation of revenues excluding foreign currency exchange impacts for the three months ended March 31, 2021 is as follows (in thousands):

​ | ​ | ​ | ​
​ | ​ | Three months ended
​ |  | March 31, 2021
Revenue as reported | ​ | $ | 101,677
Currency impact (favorable) unfavorable | ​ |  | (4,274)
Revenue excluding foreign currency exchange impacts | ​ | $ | 97,403

​

The Company’s calculation of EBITDA and Adjusted EBITDA for the three months ended March 31, 2021 and 2020 is as follows (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended
​ | ​ | March 31,
​ |  | 2021 |  | 2020
Net income as reported | ​ | $ | 11,927 | ​ | $ | 4,035
Interest expense | ​ |  | 861 | ​ |  | 1,054
(Benefit) provision for income tax | ​ |  | (6,057) | ​ |  | 1,567
Depreciation and amortization | ​ |  | 4,431 | ​ |  | 3,750
EBITDA | ​ |  | 11,162 | ​ |  | 10,406
Stock-based compensation expense | ​ |  | 797 | ​ |  | 789
Business development costs | ​ |  | 19 | ​ |  | 247
Foreign currency (gain) loss | ​ | ​ | (12) | ​ | ​ | 92
Adjusted EBITDA | ​ | $ | 11,966 | ​ | $ | 11,534

​

Liquidity and Capital Resources

The Company’s liquidity position as measured by cash and cash equivalents increased by $1,594 to a balance of $24,725 at March 31, 2021 from December 31, 2020.

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​ | ​ | 2021 vs. |
​ | ​ | Three Months Ended | ​ | 2020 | ​
​ | ​ | March 31, | ​ | Variance | ​
​ |  | 2021 |  | 2020 |  | $ |
Net cash provided by (used in) operating activities | ​ | $ | 5,567 | ​ | $ | (2,966) | ​ | $ | 8,533 | ​
Net cash used in investing activities | ​ | ​ | (3,076) |  | ​ | (16,237) | ​ |  | 13,161 | ​
Net cash (used in) provided by financing activities | ​ | ​ | (256) |  | ​ | 26,322 | ​ |  | (26,578) | ​
Effect of foreign exchange rates on cash | ​ | ​ | (641) |  | ​ | (152) | ​ |  | (489) | ​
Net increase in cash and cash equivalents | ​ | $ | 1,594 | ​ | $ | 6,967 | ​ | $ | (5,373) | ​

​

During the three months ended March 31, 2021, the increase in cash provided by operating activities is primarily due to cash provided from working capital activity in 2021 compared to 2020 and net income adjusted for non-cash items. Working capital activity in the three months ended March 31, 2020, most notably inventory, were impacted by the push out of orders related to the COVID-19 pandemic, building inventory for new product launches and purchasing additional inventory in order to secure supply.

21

Table of Contents

Cash used in investing activities in the three months ended March 31, 2021 relates entirely to purchases of property and equipment. Purchases of property and equipment were $3,076 during the three months ended March 31, 2021 compared to $1,696 during the three months ended March 31, 2020 reflecting continued commitments to capital expenditure projects supporting growth initiatives. Cash used in investing activities in the prior year period included a $14,541 outflow related to the acquisition of Dynamic Controls. Capital expenditures are expected to be between $12,000 and $15,000 for 2021.

The decrease in cash provided by financing activities in the three months ended March 31, 2021 from the three months ended March 31, 2020 reflects the Amended Revolving Facility borrowing for the acquisition of Dynamic Controls for approximately $26,000 in the first quarter of 2020. At March 31, 2021, we had $120,424 of obligations under the Amended Revolving Facility, excluding deferred financing costs.

The Amended Credit Agreement contains certain financial covenants related to minimum interest coverage and total leverage ratio at the end of each quarter. The Amended Credit Agreement also includes other covenants and restrictions, including limits on the amount of additional indebtedness, and restrictions on the ability to merge, consolidate or sell all or substantially all our assets. We were in compliance with all covenants at March 31, 2021.

As of March 31, 2021, the unused Amended Revolving Facility was $104,576. The amount available to borrow may be lower and may vary from period to period based upon our debt and EBITDA levels, which impacts our covenant calculations. The Amended Credit Agreement matures in February 2025.

There were no borrowings under the China Facility during the three months ended March 31, 2021 and 2020, respectively.

The Company declared dividends of $0.02 per share during the three months ended March 31, 2021 and 2020, respectively.

​

Although there is ongoing uncertainty related to the anticipated impact of the COVID-19 outbreak on our future results, we believe our diverse markets, and the steps we have taken to strengthen our balance sheet, such as retaining cash to support shorter term needs and extending the maturity of our revolving credit facility in the first quarter of 2020 leaves us well-positioned to manage our business through the crisis as it continues to unfold. We have reviewed numerous potential scenarios in connection with the impact of COVID-19 on our Company. Based on our analysis, we believe our existing balances of cash, the flexibility of our Amended Credit Agreement and our currently anticipated operating cash flows will be sufficient to meet our cash needs arising in the ordinary course of business for the next twelve months.

​

Item 3. Qualitative and Quantitative Disclosures about Market Risk

Foreign Currency

We have foreign operations in The Netherlands, Sweden, Germany, China, Portugal, Czech Republic, Canada, Mexico, the United Kingdom and New Zealand which expose the Company to foreign currency exchange rate fluctuations due to transactions denominated in Euros, Swedish Krona, Chinese Renminbi, Czech Krona, Canadian dollar, Mexican pesos, British Pound Sterling and New Zealand dollar, respectively. We continuously evaluate our foreign currency risk and will take action from time to time in order to best mitigate these risks. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency exposures would have had an impact of approximately $4,500 on our first quarter 2021 sales. This amount is not indicative of the hypothetical net earnings impact due to partially offsetting impacts on cost of sales and operating expenses in those currencies. We estimate that foreign currency exchange rate fluctuations during the quarter ended March 31, 2021 increased sales in comparison to quarter ended March 31, 2020 by $4,274.

We translate all assets and liabilities of our foreign operations, where the U.S. dollar is not the functional currency, at the period-end exchange rate and translate sales and expenses at the average exchange rates in effect during the period. The net effect of these translation adjustments is recorded in the condensed consolidated financial statements as comprehensive income. The translation adjustment was a loss of $4,007 and a loss of $2,428 for the first quarter of 2021 and 2020, respectively. Translation adjustments are not adjusted for income taxes as they relate to permanent investments in our foreign subsidiaries. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency net assets would have had an impact of approximately $9,900 on our foreign net assets as of March 31, 2021. Beginning in the first quarter of 2021, we began entering into contracts to hedge our short-term balance sheet exposure, primarily intercompany, that are denominated in currencies (Euro, Mexican Peso, New Zealand Dollar, Chinese Renminbi) other than the subsidiary’s functional currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in other (income) expense, net in the condensed consolidated statements of

22

Table of Contents

income and comprehensive income. The foreign currency contracts are recorded in the condensed consolidated balance sheets at fair value and resulting gains or losses are recorded in other (income) expense, net in the condensed consolidated statements of income and comprehensive income. During the first quarter of 2021, we recorded a $140 loss on foreign currency contracts which is included in other (income) expense, net and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other (income) expense, net. Net foreign currency transaction gains and losses included in other expense, net amounted to a gain of $12 and a loss of $92 for the first quarter of 2021 and 2020, respectively.

Interest Rates

Borrowings under the Amended Revolving Facility bear interest at the LIBOR Rate plus a margin of 1.00% to 1.75% (1.625% at March 31, 2021) or the Prime Rate plus a margin of 0% to 0.75% (0.625% at March 31, 2021), in each case depending on the Company’s ratio of total funded indebtedness to Consolidated trailing twelve-month EBITDA. We use interest rate derivatives to add stability to interest expense and to manage our exposure to interest rate movements. We primarily use interest rate swaps as part of our interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In February 2017, the Company entered into three interest rate swaps with a combined notional amount of $40,000 that mature in February 2022. In March 2020, the Company entered into two additional interest rate swaps with a combined notional amount of $20,000 that increases to $60,000 in March 2022 and matures in December 2024.

As of March 31, 2021, we had $120,424 outstanding under the Amended Revolving Facility (excluding deferred financing fees), of which $60,000 is currently being hedged. Refer to Note 9, Debt Obligations of the Notes to condensed consolidated financial statements for additional information about our outstanding debt. A hypothetical one percentage point (100 basis points) change in the Base Rate on the $60,424 of unhedged floating rate debt outstanding at March 31, 2021 would have approximately a $150 impact on our interest expense for the first quarter of 2021.

​

Item 4. Controls and Procedures

Conclusion regarding the effectiveness of disclosure controls and procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (principal accounting officer), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2021. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that, as of March 31, 2021, the Company’s disclosure controls and procedures were effective.

Changes in internal control over financial reporting

During the quarter ended March 31, 2021, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

​

PART II. OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed in the Company’s Form 10-K for the year ended December 31, 2020, except to the extent factual information disclosed elsewhere in this Form 10-Q relates to such risk factors. For a full discussion of these risk factors, please refer to “Item 1A. Risk Factors” in the 2020 Annual Report and 10-K.

​

23

Table of Contents

Item 5. Unregistered Sales of Equity Securities and Use of Proceeds

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Total Number of Shares |  | Maximum Number of Shares
​ | ​ | Number of Shares | ​ | Average Price Paid | ​ | Purchased as Part of Publicly | ​ | that May Yet Be Purchased
Period | ​ | Purchased (1) (2) | ​ | per Share (2) | ​ | Announced Plans or Programs | ​ | Under the Plans or Programs
01/01/21 to 01/31/21 |  | 4,553 | ​ | $ | 34.63 |  | — |  | —
02/01/21 to 02/28/21 |  | — | ​ |  | — |  | — |  | —
03/01/21 to 03/31/21 |  | 16,827 | ​ |  | 34.35 |  | — |  | —
Total |  | 21,380 | ​ | $ | ​ |  | — |  | —

​

| (1) | As permitted under the Company’s equity compensation plan, these shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of stock. Shares withheld for tax withholding obligations do not affect the total number of shares available for repurchase under any approved common stock repurchase plan. At March 31, 2021, the Company did not have an authorized stock repurchase plan in place.

​

| (2) | Shares of common stock and related per share amounts give retroactive effect for stock splits. A three-for-two common stock split, effected as a stock dividend, occurred on April 30, 2021.

​

Item 6. Other Information

None.

​

Item 7. Exhibits

​

| (a) | Exhibits
​ | ​ | ​
​ | 10.1 | Third Amendment to Employment Agreement between Allied Motion Technologies Inc. and Richard S. Warzala dated March 17, 2021. (Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed March 23, 2021.)
​ | ​ | ​
​ | 10.2 | Form of Employment Agreement (Entered into with Michael R. Leach, Robert P. Maida, Ashish R. Bendre and Geoffrey C. Rondeau each dated March 17, 2021.) (Incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed March 23, 2021.)
​ | ​ | ​
​ | 10.3 | Managing Director’s Contract of Employment between Heidrive GmbH and Helmut Pirthauer dated December 3, 2016. (Incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed March 23, 2021.)
​ | ​ | ​
​ | 10.4 | First Amendment to Managing Director’s Contract of Employment between Heidrive GmbH and Helmut Pirthauer dated March 12, 2018. (Incorporated by reference to Exhibit 10.4 to the Company’s Form 8-K filed March 23, 2021.)
​ | ​ | ​
​ | 10.5 | Second Amendment to Managing Director’s Contract of Employment between Heidrive GmbH and Helmut Pirthauer dated March 18, 2021. (Incorporated by reference to Exhibit 10.5 to the Company’s Form 8-K filed March 23, 2021.)
​ | ​ | ​
| 31.1 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 31.2 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 32.1 | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 32.2 | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 101.1 SCH | Inline XBRL Taxonomy Extension Schema Document (filed herewith).
​ | ​ | ​

24

Table of Contents

| 101.2 CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).
​ | ​ | ​
| 101.3 DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).
​ | ​ | ​
​ | 101.4 LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (filed herewith).
​ | ​ | ​
​ | 101.5 PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).
​ | ​ | ​
​ | 104 | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in exhibits 101.*) (filed herewith).
​ | ​ | ​

​

​

25

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATE: | May 5, 2021 | ALLIED MOTION TECHNOLOGIES INC.
|  | By: | /s/ Michael R. Leach
|  | Michael R. Leach
|  | Chief Financial Officer

​

​

​

26